Interestingly, knockdown of MTHFD2 in breast cancer cells significantly affected many important metabolic pathways, suggesting that MTHFD2 might be a central metabolic enzyme in cancer cells [17]. This evidence concerns the gene MTHFD2 and breast carcinoma.